Angelina Jolie’s open explanation about carrying unsure mutations in a gene associated to breast cancer sent DNA screening referrals by a roof, during slightest in a UK, a new investigate suggests.
The “Angelina effect” persisted for many months as many some-more women got genetic tests for a participation of a chronicle of a BRCA1 gene that neatly raises a risk of breast and ovarian cancer, according to a study, published Thursday in a journal Breast Cancer Research.
Researchers looked during information from some-more than 30 genetic screening clinics and services in a UK and found a some-more than two-fold boost in a series of people referred by their ubiquitous practitioners during Jun and Jul final year, compared with a same duration a year before. Jolie announced in May 2013 that she had recently undergone a double mastectomy and reconstructive surgery.
The aloft mention rates persisted by final October, according to a study.
Science NowBreast cancer and BRCA mutations: Removing healthy breast saves livesSee all related
Public announcements by celebrities about health issues mostly animate a hypochondriacs, though researchers remarkable that many of a women who came in had been procrastinating about returning for a follow-up screening.
The study’s lead investigator, Dr. Gareth Evans, who studies medical genetics and epidemiology during a University of Manchester, pronounced a materialisation could simulate a strength of Jolie’s picture as both glamorous and strong.
Amina Khan Angelina Jolies explanation that she underwent a medicine double mastectomy might seem like a intolerable pierce to some. But for many women who have dangerous patrimonial risks coded into their genes, this kind of medicine before cancer strikes serves as a viable choice that’s been growing… Angelina Jolies explanation that she underwent a medicine double mastectomy might seem like a intolerable pierce to some. But for many women who have dangerous patrimonial risks coded into their genes, this kind of medicine before cancer strikes serves as a viable choice that’s been growing… ( Amina Khan ) –>
It is misleading if a identical arise in screening has been documented in a U.S., though a British researchers pronounced there is no reason to think a materialisation was removed to England.
Since a introduction of screening in a late 1990s, a rate of precautionary shared mastectomy has risen neatly among women diagnosed with cancer in a singular breast, studies have shown.
Copyright © 2014, Los Angeles Times